This study is based on the ergonomic features of the most common surgical procedures, which require advanced techniques and relatively difficult operations, such as pancreatobiliary surgery, prostatectomy, nephrectomy, colon and rectal resection. This study id designed to verify the clinical safety and effectiveness of 'Revo-i Surgical Robot System (Model MSR-5100), developed by Mirae Company to overcome the limitations of general laparoscopic surgery.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
33
for evaluating the clinical safety and effectiveness of the automated robotic robot, Revo-i Surgical Robot System (Model MSR-5100), used for general HBP surgery
for evaluating the clinical safety and effectiveness of the automated robotic robot, Revo-i Surgical Robot System (Model MSR-5100), used for general Uro surgery
for evaluating the clinical safety and effectiveness of the automated robotic robot, Revo-i Surgical Robot System (Model MSR-5100), used for general colorectal surgery
Department of Surgery, Yonsei University College of Medicine
Seoul, South Korea
RECRUITINGOperation success rate
Surgery is complete without significant complications up to 24 hours after surgery and without conversion to other operations (laparotomy or laparoscopy)
Time frame: 24hours after operation
Operative outcome
Operation time (minute)
Time frame: immediate postoperation
Operative outcome
Intraoperative bleeding volume (ml)
Time frame: immediate postoperation
Operative outcome
Length of stay (day)
Time frame: 1 month after operation
Operative outcome
Complication rate (%)
Time frame: 1 month after operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.